TWi T085 225 Pill - white capsule-shape
Pill with imprint TWi T085 225 is White, Capsule-shape and has been identified as Propafenone Hydrochloride Extended-Release 225 mg. It is supplied by TWi Pharmaceuticals USA, Inc.
Propafenone is used in the treatment of Atrial Fibrillation; Atrial Flutter; Ventricular Tachycardia; Wolff-Parkinson-White Syndrome and belongs to the drug class group I antiarrhythmics. Risk cannot be ruled out during pregnancy. Propafenone 225 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for TWi T085 225
Propafenone Hydrochloride Extended-Release
- Imprint
- TWi T085 225
- Strength
- 225 mg
- Color
- White
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Group I antiarrhythmics
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- TWi Pharmaceuticals USA, Inc.
- Manufacturer
- TWi Pharmaceuticals, Inc.
- National Drug Code (NDC)
- 24979-0085
More about propafenone
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (69)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: group I antiarrhythmics
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.